fbpx
Medical Innovation Exchange

After oncology wind-down, TG's pivot to MS faces setback as FDA pushes approval decision

https://www.fiercebiotech.com/biotech/after-oncology-wind-down-tgs-pivot-ms-faces-setback-fda-pushes-back-approval-decision

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.